FDA warns consumers not to use off-brand versions of Ozempic, Wegovy

consumers not to use off-brand versions of the popular weight-loss drugs Ozempic and Wegovy because they might not contain the same ingredients as the prescription products and may not be safe or effective.

The trouble is that those versions, often sold online, contain a version of semaglutide that is used in lab research and has not been approved for use in people. The drugs manufactured by Novo Nordisk include brands Ozempic and Rybelsus, used to treat diabetes, and Wegovy, approved to treat obesity.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA warns consumers not to use off-brand versions of Ozempic, WegovyConsumers should only use semaglutide prescribed by a health care provider and filled by a licensed pharmacy, FDA said.
Source: wsfa12news - 🏆 338. / 59 Read more »

What is berberine, the supplement dubbed 'nature's Ozempic' on social media?As the dietary supplement berberine surges in popularity for its weight loss effects, here’s what to know about it, including how well it works and whether it’s safe.
Source: NBCNews - 🏆 10. / 86 Read more »

FDA warns about compounded versions of popular weight loss drugsFederal health officials say some medications being sold may not contain the same active ingredient as FDA-approved semaglutide products.
Source: 10News - 🏆 732. / 50 Read more »